Utilization management: A European perspective

Clinica Chimica Acta

Volumn 427, Issue , 2014, Pages 137-141

  Plebani, Mario ^a   Zaninotto, Martina ^a   Faggian, Diego ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Clinical laboratory; Cost per test; Cost containment; Demand management; Efficiency; Quality

Indexed keywords

ACCREDITATION; ARTICLE; BIOMEDICINE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DELETING TEST; DEMAND MANAGEMENT; EUROPE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; INAPPROPRIATE TEST REQUEST; LABORATORY MEDICINE; LABORATORY TEST; PATIENT CARE; PATIENT EDUCATION; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; STRATEGIC PLANNING; UTILIZATION MANAGEMENT; DIAGNOSTIC PROCEDURE; ECONOMICS; LABORATORY DIAGNOSIS; ORGANIZATION AND MANAGEMENT; STANDARDS; UTILIZATION;

CLINICAL LABORATORY SERVICES; CLINICAL LABORATORY TECHNIQUES; EUROPE; HUMANS;

EID: 84888867867     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.03.002     Document Type: Article

References (63)

1. Kongstevdt P. Essentials of managed health care 1997, Aspen, Gaithersburg, MD.
2. Porter M.E. What is value in health care?. N Engl J Med 2010, 363:2477-2481.
3. Yee K.C. Challenges of the "omics" future and pathology informatics systems: are we pathologists, clinicians, and consumers ready?. Arch Pathol Lab Med 2009, 133:938-941.
4. Zhao J.J., Liberman A. Pathologists' roles in clinical utilization management. Am J Clin Pathol 2000, 113:336-342.
5. Young D.S., Sachais B.S., Jefferies L.C. Laboratory costs in the context of disease. Clin Chem 2000, 46:967-975.
6. Barth J.H. Clinical quality indicators in laboratory medicine: a survey of current practice in the UK. Ann Clin Biochem 2011, 48:238-240.
7. Plebani M. Laboratory medicine: value for patients is the goal. Clin Chem 2007, 53:1873-1874.
8. Rutledge J., Xu M., Simpson J. Application of the Toyota production system improves core laboratory operations. Am J Clin Pathol 2010, 133:24-31.
9. International Organization for Standardization ISO 15189:2007: medical laboratories: particular requirements for quality and competence 2007, International Organization for Standardization, Geneva, Switzerland.
10. Kilinc C. Laboratory quality management systems: missions, goals and activities in quality. Clin Biochem 2009, 42:301-302.
11. Noble M.A. IQLM Network: meeting goals-meeting needs. 2005 IQLM Conference 29 April 2005, [see http://cdc.confex.com/cdc/viewHandout.cgi?uploadid=720 last checked 5 January 2011].
12. Barth J.H. Selecting clinical quality indicators for laboratory medicine. Ann Clin Biochem 2012, 49:257-261.
13. Piva E., Plebani M. Interpretative reports and critical values. Clin Chim Acta 2009, 404:52-58.
14. Lippi G., Plebani M. Primary blood tubes mixing: time for updated recommendations. Clin Chem Lab Med 2012, 50:599-600.
15. Hammerer-Lercher A., Collinson P., van Dieijen-Visser M.P., et al. Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE). Clin Chem Lab Med Jan 2013, 19:1-6. 10.1515/cclm-2012-0510.
16. Lundberg G.D. How clinicians should use the diagnostic laboratory in a changing medical world. Clin Chim Acta 1999, 280:3-11.
17. McQueen M.J. Evidence-based medicine: its application to laboratory medicine. Drug Monit 2000, 22:1-9.
18. Smellie W.S., Galloway M.J., Chinn D., Gedling P. Is clinical practice variability the major reason for differences in pathology requesting patterns in general practice?. J Clin Pathol 2002, 55:312-314.
19. Plebani M. Appropriateness in programs for continuous quality improvement in clinical laboratories. Clin Chim Acta 2003, 333:131-139.
20. Plebani M., Laposata M., Lundberg G.D. The brain-to-brain loop concept for laboratory testing 40years after its introduction. Am J Clin Pathol 2011, 136:829-833.
21. European diagnostic manufacturers association European Diagnostic Market Association (EDMA) in 2010 [accessed January 14th2013]. http://www.edma-ivd.eu/.
22. An independent review for the Department of Health. Report of the second phase of the review of NHS pathology services in England http://www.rcpath.org/Resources/RCPath/Migrated%20Resources/Documents/R/Review_Report_final_proof08.pdf.
23. Ministero della Salute, del Lavoro e delle Politiche sociali Linee di Indirizzo per la Riorganizzazione dei Servizi di Medicina di Laboratorio nel Servizio Sanitario Nazionale [accessed January 24th, 2013]. http://www.agenas.it/innov_sperim_sviluppo/Riorganiz-Medicina_Laboratorio.pdf.
24. Zaninotto M., Plebani M. The "hospital central laboratory": automation, integration and clinical usefulness. Clin Chem Lab Med 2010, 48:911-917.
25. Langlois M.R., Wallemacq P. The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC). Clin Chem Lab Med 2009, 47:1195-1201.
26. Cooper R., Kaplan R.S. Measure costs right: make the right decisions. Harv Bus Rev September/October 1988, 96-103.
27. Cao P., Toyabe S., Kurashima S., Okada M., Akazawa K. A modified method of activity-based costing for objectively reducing cost drivers in hospitals. Methods Inf Med 2006, 45:462-469.
28. Barletta G., Zaninotto M., Faggian D., Plebani M. Shop for quality or quantity? Volumes and costs in clinical laboratories. Clin Chem Lab Med 2013, 51:295-301.
29. Zaninotto M., Tasinato A., Padoan A., et al. Effects of sample transportation on commonly requested laboratory tests. Clin Chem Lab Med 2012, 50:1755-1760.
30. Plebani M., Lippi G. Is laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed. Clin Biochem 2010, 43:939-941.
31. Plebani M. The CCLM contribution to improvements in quality and patient safety. Clin Chem Lab Med 2013, 51:39-46.
32. Zaninotto M., Tasinato A., Padoan A., et al. An integrated system for monitoring the quality of sample transportation. Clin Biochem 2012, 45:688-690.
33. Price C.P. Medical and economic outcomes of point-of-care testing. Clin Chem Lab Med 2002, 40:246-251.
34. Barth J.H. Clinical quality indicators in laboratory medicine. Ann Clin Biochem 2012, 49:9-16.
35. Plebani M. Charting the course of medical laboratories in a changing environment. Clin Chim Acta 2002, 319:87-100.
36. Smellie W.S.A. Demand management and test request rationalization. Ann Clin Biochem 2012, 49:323-336.
37. Young D.W. An aid to reducing unnecessary investigations. BMJ 1980, 281:1610-1615.
38. Bloomgarden Z., Sidel V.W. Evaluation of utilization of laboratory tests in a hospital emergency room. Am J Public Health 1980, 70:525-528.
39. Fryer A.A., Hanna F.W. Managing demand for pathology tests: financial imperative or duty of care?. Ann Clin Biochem 2009, 46:435-437.
40. Trinick T.R., Archbold G.P.R., Crooks G.M., Damani N.N., Hughes D.F.C., Jones F.G.C. Appropriateness of laboratory investigations: report of a Crest working group September 2000, CREST, Belfast.
41. Fryer A.A., Smellie W.S.A. Managing demand for laboratory tests; a laboratory toolkit. J Clin Pathol 2013, 66:62-72.
42. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease 2002, National Academy of Clinical Biochemistry (NACB), Washington (DC). L.M. Demers, C.A. Spencer (Eds.).
43. Loeb S., Catalona W.J. Prostate-specific antigen in clinical practice. Cancer Lett 2007, 249:30-39.
44. Tozzoli R., Bizzaro N., Tonutti E., et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic disease. Am J Clin Pathol 2002, 117:316-324.
45. Thygensen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653. on behalf of the Joint ESC/ACCF/AHA/WHF force for the Redefinition of Myocardial Infarction.
46. Thygensen K., Alpert J.S., Jaffe A.S. Third universal definition of myocardial infarction. JACC 2012, 60:1581-1598. on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction.
47. Goodacre S., Tokala P., Carroll C., et al. Systematic review, meta-analysis and economic modeling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess 2013, 17:1-188.
48. Thokala P., Goodacre S.W., Collinson P.O., et al. Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction. Heart 2012, 98:1498-1503.
49. Keller T., Zeller T., Peetz D., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
50. Verboeket-van de Venne W.P., Aakre K.M., Watine J., Oosterhuis W.P. Reflective testing: adding value to laboratory testing. Clin Chem Lab Med 2012, 50:1249-1252.
51. Plebani M. What information on quality specifications should be communicated to clinicians, and how?. Clin Chim Acta 2004, 346:25-35.
52. Lang TF. National Minimum Re-testing Interval Project: a final report detailing consensus recommendations for minimum re-testing intervals for use in Clinical Biochemistry. Assoc Clin Biochem in press.
53. Laposata M.E., Laposata M., Van Cott E.M., Buchner D.S., Kashalo M.S., Dighe A.S. Physician survey of a laboratory medicine interpretive service and evaluation of the influence of interpretations on laboratory test ordering. Arch Pathol Lab Med 2004, 128:1424-1427.
54. Barlow I.M. Are biochemistry interpretative comments helpful? Results of a general practitioner and nurse practitioner survey. Ann Clin Biochem 2008, 45:88-90.
55. Barlow I.M. Do interpretative comments influence patient management and do our users approve of the laboratory 'adding on' requests? A follow-up General Practitioner and Nurse Practitioner survey. Ann Clin Biochem 2009, 46:85-86.
56. Kilpatrick E.S., Freedman D.B. A national survey of interpretative reporting in the UK. Ann Clin Biochem 2011, 48:317-320. National Clinical Biochemistry Audit Group.
57. Plebani M. Interpretative commenting: a tool for improving the laboratory-clinical interface. Clin Chim Acta 2009, 404:46-51.
58. Institute of Medicine Committee on Quality of Health Care in America To err is human: building a safer health system 2000, National Academic Press, Washington, DC.
59. Plebani M., Sciacovelli L., Marinova M., Marcuccitti J., Chiozza M.L. Quality indicators in laboratory medicine: a fundamental tool for quality and patient safety. Clin Biochem Dec 5 2012, [pii: S0009-9120(12)00664-9 [Epub ahead of print]]. 10.1016/j.clinbiochem.2012.11.028.
60. Plebani M., Chiozza M.L., Sciacovelli L. Towards harmonization of quality indicators in laboratory medicine. Clin Chem Lab Med 2013, 51:187-195.
61. Sciacovelli L., O'Kane M., Skaik Y.A. Quality Indicators in Laboratory Medicine: from theory to practice. Preliminary data from the IFCC Working Group Project "Laboratory Errors and Patient Safety". Clin Chem Lab Med 2011, 49:835-844. IFCC WG-LEPS.
62. Shcolnik W., Albuquerque de Olivera C., Sà de Sao Josè A., et al. Seven years' experience of Brazilian Society of Clinical Pathology and Control Lab. Clin Chem Lab Med 2012, 50:1923-1934.
63. Janssens P.M. Managing the demand for laboratory testing: options and opportunities. Clin Chim Acta 2010, 411:1596-1602.